A Real-World Comparison of First-Line Regimens in Transplant Ineligible Patients with Multiple Myeloma

被引：0
|
作者：
Abdallah, Nadine [1 ]
Chakraborty, Rajshekhar [2 ]
Visram, Alissa [3 ]
Gayowsky, Anastasia [4 ]
Pond, Gregory [5 ]
Seow, Hsien [5 ]
Kumar, Shaji [1 ]
Mian, Hira [5 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Columbia Univ, Med Ctr, New York, NY USA
[3] Univ Ottawa, Ottawa, ON, Canada
[4] Inst Evaluat Sci, Hamilton, ON, Canada
[5] McMaster Univ, Hamilton, ON, Canada
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-318
引用
收藏
页码：S217 / S218
页数：2
相关论文
共 50 条
  • [21] Machine learning-assisted identification of optimal first-line treatment for newly diagnosed, transplant ineligible multiple myeloma
    Koo, Jamin
    Park, Sung-Soo
    Min, Chang-Ki
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S146 - S146
  • [22] First-line therapy for non-transplant eligible patients with multiple myeloma: direct and adjusted indirect comparison of treatment regimens on the existing market in Germany
    Kuhr, Kathrin
    Wirth, Daniel
    Srivastava, Kunal
    Lehmacher, Walter
    Hellmich, Martin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (03) : 257 - 265
  • [23] First-line therapy for non-transplant eligible patients with multiple myeloma: direct and adjusted indirect comparison of treatment regimens on the existing market in Germany
    Kathrin Kuhr
    Daniel Wirth
    Kunal Srivastava
    Walter Lehmacher
    Martin Hellmich
    European Journal of Clinical Pharmacology, 2016, 72 : 257 - 265
  • [24] Unravelling transplant-ineligible newly diagnosed multiple myeloma treatment in real-world practice in Spain: CARINAE study
    Casanova Espinosa, Maria
    Hernandez Garcia, Miguel Teodoro
    Soler Campos, Juan Alfons
    Herraez Rodriguez, Susana
    Moreno Belmonte, Maria Jose
    Gonzalez-Pardo, Miriam
    Gironella Mesa, Mercedes
    de Arriba de la Fuente, Felipe
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S93 - S94
  • [25] A glimpse into transplant-ineligible newly diagnosed multiple myeloma treatment in real-world practice in Spain: carinae study
    de Arriba de la Fuente, Felipe
    Hernandez Garcia, Miguel Teodoro
    Soler Campos, Juan Alfons
    Herraez Rodriguez, Susana
    Jose Moreno, Ma
    Conzalez Pardo, Miriam
    Gironella Mesa, Mercedes
    Casanova Espinosa, Maria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S143 - S144
  • [26] Age (≤75 years) and Not Choice of First-Line Therapy Improves Overall Survival in Transplant Ineligible NDMM Patients: Results from a Large UK Real-World Dataset
    Djebbari, Faouzi
    Sharpley, Faye A.
    Sweeney, Connor
    Vallance, Grant
    Peniket, Andy
    Ferguson, Lisa
    McLain-Smith, Susan
    Kothari, Jaimal
    Ramasamy, Karthik
    BLOOD, 2017, 130
  • [27] Unravelling Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain: The CARINAE Study
    de la Fuente, Felipe de Arriba
    Mesa, Mercedes Gironella
    Garcia, Miguel Teodoro Hernandez
    Campos, Juan Alonso Soler
    Rodriguez, Susana Herraez
    Belmonte, Maria Jose Moreno
    Lopez, Teresa Regueiro
    Gonzalez-Pardo, Miriam
    Espinosa, Maria Casanova
    PHARMACEUTICALS, 2024, 17 (10)
  • [28] How First-Line Therapy is Changing in Transplant-Eligible Multiple Myeloma Patients
    Houbaida, Yasmine
    Del Giudice, Maria Livia
    Galimberti, Sara
    Buda, Gabriele
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2025, 17 (01)
  • [29] Real-world multiple myeloma front-line treatment and outcomes by transplant in the United States
    Richter, Joshua
    Pan, Darren
    Salinardi, Taylor
    Rice, Megan S.
    EJHAEM, 2023, 4 (04): : 984 - 994
  • [30] Real-World Multiple Myeloma Front-Line Treatment and Outcomes By Transplant in the United States
    Richter, Joshua
    Pan, Darren
    Salinardi, Taylor
    Rice, Megan S.
    BLOOD, 2022, 140 : 7187 - 7188
12345